FDA approves Bayer blood-glucose monitoring system

TARRYTOWN, N.Y. — Regulators have approved a new blood-glucose monitoring system made by Bayer HealthCare, the company said.



Bayer announced the Food and Drug Administration's approval of Contour Next EZ, which includes a meter and test strip sensors that the company said would improve accuracy.



Bayer said the system is being introduced on a market-by-market basis and will be available in the United States this summer.

Interested in this topic? Sign up for our weekly DSN Collaborative Care e-newsletter.